Drug Profile
Obatoclax
Alternative Names: CEP-41601; GX 15-070; GX15-070MS; Obatoclax mesylateLatest Information Update: 07 Mar 2018
Price :
$50
*
At a glance
- Originator Gemin X Biotechnologies
- Class Antineoplastics; Pyrroles; Small molecules
- Mechanism of Action Apoptosis stimulants; Autophagy stimulants; Proto-oncogene protein c-bcl-2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acute myeloid leukaemia; Aplastic anaemia; Chronic lymphocytic leukaemia; Follicular lymphoma; Hodgkin's disease; Mantle-cell lymphoma; Multiple myeloma; Myelodysplastic syndromes; Myelofibrosis; Non-small cell lung cancer; Precursor cell lymphoblastic leukaemia-lymphoma; Small cell lung cancer; Systemic mastocytosis
Most Recent Events
- 31 Dec 2013 Discontinued - Phase-I for Multiple myeloma in USA (IV)
- 31 Dec 2013 Discontinued - Phase-I/II for Chronic lymphocytic leukaemia in USA and Canada (IV)
- 31 Dec 2013 Discontinued - Phase-I/II for Mantle cell lymphoma (Combination therapy, Second-line therapy or greater) in USA (IV)